5941153bb7
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
3.2 KiB
3.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product | Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product | us/states/md | Maryland General Assembly | 2021 | HB 429 | Maryland HB 429 (2021) |
|
enacted |
|
3 | 13 | 2 | 2021-01-15 | 2021-05-18 | openstates | ocd-bill/b7a8d71f-a285-4f1b-bdf2-1d1bc311fb5a | http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb0429?ys=2021RS&search=True | 2212f340869b974b0d95a886c9a907b48304eaa3c415bf5f988078c3e40d79be | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Maryland HB 429 (2021) — Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Chapter - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product (committee substitute) — source
- First - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product (committee substitute) — source
- Third - Pharmacists - Required Notification and Authorized Substitution - Lower-Cost Drug or Device Product (committee substitute) — source
Votes
- On Third Reading — 128–0 (pass) · lower
- On Third Reading — 45–0 (pass) · upper
Sponsors
- Shetty — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2021-01-15 First Reading Health and Government Operations
referral-committee - 2021-01-21 Hearing 2/03 at 2:30 p.m.
- 2021-02-24 Favorable with Amendments Report by Health and Government Operations
committee-passage-favorable - 2021-02-25 Favorable with Amendments {
committee-passage-favorable - 2021-02-25 Second Reading Passed with Amendments
- 2021-02-26 Third Reading Passed
passage - 2021-03-02 Referred Education, Health, and Environmental Affairs
referral-committee - 2021-04-10 Favorable Report by Education, Health, and Environmental Affairs
committee-passage-favorable - 2021-04-10 Favorable Adopted
committee-passage-favorable - 2021-04-10 Second Reading Passed
- 2021-04-12 Third Reading Passed
passage - 2021-04-12 Returned Passed
- 2021-05-18 Approved by the Governor - Chapter 162
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/b7a8d71f-a285-4f1b-bdf2-1d1bc311fb5a. Confidence: reported (aggregated from official Maryland legislature records).